Market & patient access · BeNeLux · Since 2019
Reimbursed
Patient Access consultancy
Axes Health helps biotech and pharmaceutical companies to bridge the gap between regulatory approval and market entry, by managing early access programs, pricing and reimbursement for orphan drugs across the Benelux region.
03
Real World Data
Strenghten your value proposition
02
Pricing & Reimbursement
At the core of your access strategy
01
Guided Patient Access
From early access to reimbursement
03
Our approach
Strategic engagement and executional excellence with deep respect for the patient’s voice.
02
Our expertise
Navigating Pricing & Reimbursement, Guided Patient Access and Real-World Data.
01
Our Purpose
Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully
Key Insights
Bringing innovative medicines to patients,
sustainably and meaningfully.
We embrace working in cross-functional teams and believe in the power of collaboration throughout the product life cycle — embedding patient access from clinical development towards the creation of real-world data.
Therapeutic Domains
Deep Cross-Domain Experience
We bring extensive experience across a broad range of therapeutic domains
Orphan Diseases
Neurology
Respiratory
Dermatology
Oncology
Cardiology
Haematology
Nephrology
Landscape
Assessment
An in-depth analysis of the current landscape, unmet needs, and payer perceptions.
Value
Proposition
Crafting a compelling value story and gathering necessary clinical and economic evidence.
Strategy
Development
Defining the optimal pricing, contracting, and access strategy for each target market.
Execution &
Launch
Following up on addressing clinical and budgetary uncertainties to maintain patient access.
Our Integrated Approach
A Systematic Path to Access
A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.
Why Choose Axes Health
Executional Excellence, Patient-First
Strategic engagement and executional excellence with deep respect for the patient's voice.
Recognised executional excellence in delivering complex market access strategies across Benelux markets.
Deep respect for the patient's voice integrated throughout all our strategic planning and execution.
Unmatched expertise in rare diseases with proven track records across orphan disease portfolios.
Respected partner by health authorities with established relationships across European regulatory bodies.
Our Expertise
Integrated Services
Navigating Pricing & Reimbursement, Guided Patient Access and Real-World Data to bring innovative medicines to patients sustainably and meaningfully.